We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Design and Testing – Products

Labguru Announces $1M Pro-bono Program for COVID-19 Treatment Developers content piece image
Product News

Labguru Announces $1M Pro-bono Program for COVID-19 Treatment Developers

BioData is offering a pro-bono program allowing free access to its flagship Labguru electronic laboratory notebook (ELN) to those working on COVID-19 treatment or vaccine development, up to a total value of $1M.
Proteomics Enters the COVID-19 Fight content piece image
Product News

Proteomics Enters the COVID-19 Fight

SomaLogic has launched a new initiative to deploy their proteomic technology against the coronavirus pandemic.
Carterra to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC) content piece image
Product News

Carterra to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)

Carterra® Inc. and La Jolla Institute for Immunology (LJI) have announced that they will use Carterra’s proprietary LSA™ platform to screen hundreds of antibodies in just a few days.

OPENCORONA Consortium: Collaborating to Develop a COVID-19 Vaccine content piece image
Product News

OPENCORONA Consortium: Collaborating to Develop a COVID-19 Vaccine

Cobra and the Karolinska Institutet have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium.
N4 Pharma Exploring How Nuvec® Can Be Used To Help Fight COVID-19 content piece image
Product News

N4 Pharma Exploring How Nuvec® Can Be Used To Help Fight COVID-19

N4 Pharma has announced that it will be undertaking a proof of concept research project using a COVID-19 DNA plasmid for the purpose of demonstrating the ability of Nuvec® to be used as a delivery system by potential collaboration partners developing COVID-19 DNA or RNA vaccines.
SARS-CoV-2 Gene Variants Provide Clues to Coronavirus’ Epidemiology content piece image
Product News

SARS-CoV-2 Gene Variants Provide Clues to Coronavirus’ Epidemiology

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable and could increase the effectiveness of vaccines in development.
Sartorius Supports the Development of SARS-CoV-2 Vaccine Candidate content piece image
Product News

Sartorius Supports the Development of SARS-CoV-2 Vaccine Candidate

Sartorius has supported CanSino Biologics Inc. and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences in China in their development of the first vaccine candidate against the novel coronavirus SARS-CoV-2 to enter clinical trials.
ATCC Partners with Global Scientific Community to Respond to the Coronavirus Pandemic content piece image
Product News

ATCC Partners with Global Scientific Community to Respond to the Coronavirus Pandemic

ATCC has announced it is expanding its support for the U.S. and international research and development communities to respond to the growing coronavirus pandemic.
Collaborative to Fund Lung Cancer Immunotherapy Clinical Trial content piece image
Product News

Collaborative to Fund Lung Cancer Immunotherapy Clinical Trial

Vaccitech has announced that it has entered into a clinical partnership with Cancer Research UK to develop a novel immunotherapy as a treatment option for patients with non-small cell lung cancer.
Funding Awarded For Yellow Fever Vaccine Development content piece image
Product News

Funding Awarded For Yellow Fever Vaccine Development

Newcells Biotech has announced that they have been awarded further funding to continue development of their model of the human liver, designed for the routine assessment of Yellow Fever vaccine attenuation.
Advertisement